Kodikaz Awarded Research Seed Grant from Biolocity

Kodikaz was awarded a Seed grant from Biolocity.  The competitive grant process was awarded to help the company further the product development of its targeted cell specific Zip-Code technology for clinical applications in Multiple Myeloma.  The grant is for 6 months of work commencing March 2020.